Combined level of burden including psychosocial symptoms (e.g. irritability, forgetfulness), physical symptoms (e.g. headaches), genital symptoms, sexual dysfunction and vasomotor symptoms (hot flushes and night sweats)
Short-term: <20 weeks
Medium-term: ≥20 weeks
Frequency of hot flushes
Hot flush ‘bother’
Other menopausal symptoms
Treatment-induced menopause: Exclusively breast cancer populations
Short-term benefit of psychological interventions in comparison to no treatment or control
Hot flush bother: Standardized mean difference (SMD) −0.54 (95% CI, −0.74 to −0.35; P < 0.001)
Menopausal symptoms: SMD −0.34 (95% CI, −0.52 to −0.15; P < 0.001)
Medium-term benefit of psychological interventions in comparison to no treatment or control
Hot flush bother: SMD −0.38 (95% CI, −0.58 to −0.18; P < 0.001)
Subgroup analysis of both treatment-induced menopause and natural menopause demonstrated positive short-term and medium-term benefit of psychological interventions
Short-term induced: SMD −0.47 (95% CI, −0.69 to −0.25; P < 0.001)
Short-term natural: SMD −0.85 (95% CI, −1.11 to −0.59; P < 0.001)
Too few studies to report accurately regarding sexual functioning
Psychological treatments such as mindfulness successfully reduced bother of hot flushes in short- and medium-term follow- up, as well as menopausal symptoms overall in the short-term
Because hot flush frequency was not impacted, authors suggest the mechanism of these interventions is to enhance coping skills and thus reduce impact of symptoms
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan